Allergan to file ubrogepant for migraine early next year
admin 18th October 2018 Uncategorised 0Allergan is gearing up to file its oral CGRP receptor ubrogepant in the US for the treatment of migraine, following the success and completion of two safety studies.
More: Allergan to file ubrogepant for migraine early next year
Source: News